Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
LEADER commenced in September 2010, and enrollment concluded in April 2012. There were 9,340 patients enrolled at 410 sites in 32 countries. The mean age of patients was 64.3 ± ...